CA2153778A1 - Methode d'utilisation de polynucleotides, d'oligonucleotides et de leurs derives pour traiter divers etats maladifs - Google Patents

Methode d'utilisation de polynucleotides, d'oligonucleotides et de leurs derives pour traiter divers etats maladifs

Info

Publication number
CA2153778A1
CA2153778A1 CA002153778A CA2153778A CA2153778A1 CA 2153778 A1 CA2153778 A1 CA 2153778A1 CA 002153778 A CA002153778 A CA 002153778A CA 2153778 A CA2153778 A CA 2153778A CA 2153778 A1 CA2153778 A1 CA 2153778A1
Authority
CA
Canada
Prior art keywords
derivatives
disease states
various disease
polynucleotides
oligonucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002153778A
Other languages
English (en)
Other versions
CA2153778C (fr
Inventor
Arsinur Burcoglu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2153778A1 publication Critical patent/CA2153778A1/fr
Application granted granted Critical
Publication of CA2153778C publication Critical patent/CA2153778C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/117—Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/18—Type of nucleic acid acting by a non-sequence specific mechanism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002153778A 1993-01-13 1994-01-13 Methode d'utilisation de polynucleotides, d'oligonucleotides et de leurs derives pour traiter divers etats maladifs Expired - Lifetime CA2153778C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US239593A 1993-01-13 1993-01-13
US08/002,395 1993-01-13
PCT/US1994/000638 WO1994015621A1 (fr) 1993-01-13 1994-01-13 Procede d'utilisation de polynucleotides, d'oligonucleotides et de leurs derives pour traiter divers etats pathologiques

Publications (2)

Publication Number Publication Date
CA2153778A1 true CA2153778A1 (fr) 1994-07-21
CA2153778C CA2153778C (fr) 2004-07-06

Family

ID=21700564

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002153778A Expired - Lifetime CA2153778C (fr) 1993-01-13 1994-01-13 Methode d'utilisation de polynucleotides, d'oligonucleotides et de leurs derives pour traiter divers etats maladifs

Country Status (4)

Country Link
EP (1) EP0678029A1 (fr)
AU (1) AU692433B2 (fr)
CA (1) CA2153778C (fr)
WO (1) WO1994015621A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699985B2 (en) 1991-08-21 2004-03-02 Arsinur Burcoglu Method of treating HIV infection and related secondary infections thereof
US5977083A (en) * 1991-08-21 1999-11-02 Burcoglu; Arsinur Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
KR0157487B1 (ko) * 1992-03-16 1998-10-15 비. 린네 파샬 단백질 키나아제 c의 올리고뉴클레오티드 조절
AU754242B2 (en) * 1997-04-28 2002-11-07 Arsinur Burcoglu Method of treating HIV infection and related secondary infections thereof
JP2003523721A (ja) 1998-12-31 2003-08-12 カイロン コーポレイション 抗原性ｈｉｖｃ型ポリペプチドをコードするポリヌクレオチド、ポリペプチド、およびそれらの使用
US7211659B2 (en) 2001-07-05 2007-05-01 Chiron Corporation Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
US7098189B2 (en) 2002-12-16 2006-08-29 Kimberly-Clark Worldwide, Inc. Wound and skin care compositions
US7485666B2 (en) 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
US20120177619A1 (en) 2009-09-23 2012-07-12 Valerio Di Nicola Composition comprising a haematic component and its use for the treatment of degenerative joint disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE31924B1 (en) * 1966-12-23 1973-02-21 Merck & Co Inc Pharmaceutical compositions comprising polynucleotides
IT1170215B (it) * 1983-09-12 1987-06-03 Crinos Industria Farmaco Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta
IT1206341B (it) * 1984-02-16 1989-04-14 Crinos Industria Farmaco Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
US4795744A (en) * 1986-07-17 1989-01-03 Hem Research, Inc. Modulation of AIDS virus-related events by double-stranded RNAS

Also Published As

Publication number Publication date
AU6090494A (en) 1994-08-15
WO1994015621A1 (fr) 1994-07-21
EP0678029A1 (fr) 1995-10-25
AU692433B2 (en) 1998-06-11
CA2153778C (fr) 2004-07-06

Similar Documents

Publication Publication Date Title
GR3024597T3 (en) 7-deazapurine modified oligonucleotides
WO1999054326A8 (fr) Dihydropyrimidines
CA2174494A1 (fr) Benzofuranes
AU4098096A (en) 2,8-disubstituted quinazolinones
ITRM940150A0 (it) Procedimento per il trattamento di acque di scarico fortemente colorate.
WO1998028317A3 (fr) Synthese chimique d'analogues de nucleosides et leur incorporation dans des polynucleotides
WO2000018439A3 (fr) Utilisation de marqueurs de neoangiogenese pour diagnostiquer et traiter des tumeurs
AU4329396A (en) Use of 3,4-diphenylchromans
ITTO950099A0 (it) Catetere, particolarmente per il trattamento di aritmie cardiache.
WO1995006764A3 (fr) Oligonucleotides ayant une activite de segmentation de l'arn
CA2153849A1 (fr) Methode pour ameliorer l'activite de reproduction des verrats en leur donnant une nourriture speciale
CA2153778A1 (fr) Methode d'utilisation de polynucleotides, d'oligonucleotides et de leurs derives pour traiter divers etats maladifs
AU6859096A (en) Substituted cyclohexylamines as central nervous system agents
BR9609631A (pt) Isocromanos 1,6-dissubstituídos para tratamento de cefaléias de enxaqueca
NO975791D0 (no) Fremgangsmåte for fremstilling av spraybare, kationiske biopolymerer
HUP9602640A2 (en) Substituted benzoyl-guanidine derivatives, process for producing them, pharmaceutical compositions containing them and the use of the compds.
CA2286296A1 (fr) Inhibiteurs pour le recepteur de l'urokinase
GB2287953B (en) High stability, organic tanning processes
ITRM950180V0 (it) Allestimenti per lo svolgimento del gioco "wormhole action match".
IT1277888B1 (it) Schermi elettromagnetici per termoterapia.
EP0663207A3 (fr) Procédé de préparation de sel de bambou.
AU1194397A (en) Fluorophenyl-triazine and pyrimidine derivatives as compounds acting on the central nervous system
ZA929909B (en) Agricultural use of certain compounds, compositions and methods for producing said compounds.
WO1998050419A3 (fr) 4-azasteroides
AU2616595A (en) Substituted 2,3-cycloalkenopyridines, process for preparing the same, agents containing the same and their use as pestic ides and fungicides

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20140113